VBI Vaccines, Inc. - Ordinary Shares (NASDAQ:VBIV) just announced the details of its long awaited phase III program in hepatitis B. The program, if successful,
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Power Solutions International Inc. (NASDAQ:PSIX) reported that Frontline Ltd has